1 option
INFbeta therapy for COVID-19 : the new SNG001 drug / Stephen Holgate.
- Format:
- Sound recording
- Author/Creator:
- Holgate, S. T., speaker.
- Series:
- Henry Stewart talks. Biomedical & life sciences collection. Research and clinical interviews.
- Research and clinical interviews, 2056-452X
- Language:
- English
- Subjects (All):
- Antiviral agents--Development.
- Antiviral agents.
- Clinical trials.
- Coronavirus infections--Chemotherapy.
- Coronavirus infections.
- COVID-19 (Disease)--Treatment.
- COVID-19 (Disease).
- Interferon.
- Antiviral Agents--administration & dosage.
- Clinical Trials as Topic.
- Coronavirus Infections.
- COVID-19 Drug Treatment.
- Drug Delivery Systems.
- Interferon-beta--administration & dosage.
- Interferon-beta--therapeutic use.
- Nebulizers and Vaporizers.
- SARS-CoV-2.
- Treatment Outcome.
- Medical Subjects:
- Antiviral Agents--administration & dosage.
- Clinical Trials as Topic.
- Coronavirus Infections.
- COVID-19 Drug Treatment.
- Drug Delivery Systems.
- Interferon-beta--administration & dosage.
- Interferon-beta--therapeutic use.
- Nebulizers and Vaporizers.
- SARS-CoV-2.
- Treatment Outcome.
- Genre:
- Sound recordings.
- Physical Description:
- 1 online resource (1 streaming audio file (10 min.)).
- Other Title:
- INFβ therapy for COVID-19 : the new SNG001 drug
- Interferon-beta therapy for COVID-19 : the new SNG001 drug
- Place of Publication:
- London : Henry Stewart Talks, 2020.
- System Details:
- Mode of access: World Wide Web.
- Contents:
- Contents: Why INFβ was chosen as a therapy for COVID-19
- Previous use of INFβ by inhalation
- Safety of INFβ as a therapy
- SNG001 mode of delivery
- SNG001 clinical trials and future prospects.
- Notes:
- Audio interview.
- Title from title frames.
- Publisher Number:
- 8172 Henry Stewart Talks
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.